CS logo
small CS logo
S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena

Roma, Italy
General hospital in Italy
Via Elio Chianesi, 53, 00144 Roma RM

About S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gruppo Italiano Malattie EMatologiche dell'Adulto
15
Fondazione Italiana Linfomi ONLUS
4
Incyte Corporation
1
Total Rows: 3

Clinical Trials at S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena


During the past decade, S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11001100220000001100Started TrialsCompleted Trails201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia
2001-12-01
2011-02-01
Completed
105
"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients
2007-11-01
2020-01-28
Completed
102
Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia
2008-12-01
2013-10-23
Completed
60
Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia
2010-04-01
2017-10-31
Completed
76
GIMEMA CLL0809 Study (BendOfa)
2010-12-01
2014-07-01
Completed
49
De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients
2011-06-01
2020-12-01
Unknown status
60
Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia
2012-01-01
2018-07-10
Completed
515
Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
2012-09-11
2019-05-05
Terminated
144

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena


According to Clinical.Site data, the most researched conditions in "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena" are "Acute Lymphoblastic Leukemia" (2 trials), "Acute Myeloid Leukemia" (2 trials), "BCR-ABL Positive" (2 trials), "Leukemia" (2 trials) and "ALL Ph Positive" (1 trials). Many other conditions were trialed in "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena" in a lesser frequency.

Clinical Trials Intervention Types at S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena


Most popular intervention types in "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena" are "Drug" (14 trials), "Other" (3 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Allogeneic SCT or Autologous SCT" (1 trials), "Allogeneic stem cell transplantation" (1 trials), "Azacitidine" (1 trials), "Bendamustine" (1 trials) and "Chemotherapy + Blinatumomab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena


The vast majority of trials in "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena" are 20 trials for "All" genders.

Clinical Trials Status at S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena


Currently, there are NaN active trials in "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status